Physician profile
Jonathan C Weeks
NPI 1376557439
$326.39
in general payments reported to CMS, 2019-2025
12 companies · $52.56 in 2025
The $52.56 reported for 2025 was less than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $157 · 2021: $117 · 2025: $52.56.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $52.56.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $52.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $57.86 | 2020-2021 | |
| Arbor Pharmaceuticals, INC. | $50.43 | 2020-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $43.62 | 2020 | |
| Boston Scientific Corporation | $36.20 | 2025 | Wavewriter Alpha Prime 16 |
| Biohaven Pharmaceuticals, INC. | $30.48 | 2021 | |
| Medtronic USA, INC. | $23.57 | 2020 | |
| Medtronic, INC. | $19.08 | 2021 | |
| Merck Sharp & Dohme LLC | $16.36 | 2025 | Bridion |
| Biodelivery Sciences International, INC. | $13.48 | 2020 | |
| Almatica Pharma LLC | $12.07 | 2021 | |
| Lilly USA, LLC | $11.88 | 2021 | |
| Zyla Life Sciences, INC. | $11.36 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Weeks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.